BIOMARKERS IN DRUG DEVELOPMENT A Handbook of Practice, Application, and Strategy

• Other Authors: Bleavins, Michael R. (edited), Carini, Claudio (edited), Jurima-Romet, Malle (edited), Rahbari, Ramin (edited)
• Format: Book
• Language: English
• Published: Hoboken, N.J. JOHN WILEY & SONS, INC., PUBLICATION 2010
• Subjects: Biomarkers, Pharmacological; Drug Design; Drug Discovery
• Online Access: Click Here to View Status and Holdings.
• Physical Description: xvii, 744 pages illustrations 24 cm
• Bibliography: Includes bibliographical references and index
• ISBN: 9780470169278

As pharmaceutical companies struggle to improve the success rate and cost-effectiveness of the drug development process, biomarkers have emerged as a valuable tool. This book synthesizes and reviews the latest efforts to identify, develop, and integrate biomarkers as a key strategy in transnational medicine and the drug development process. Filled with case studies, the book demonstrates how biomarkers can improve drug development timelines, lower costs, facilitate better compound selection, reduce late-stage attrition, and open the door to personalized medicine." "Each of the thirty-eight chapters was contributed by one or more leading experts, including scientists from biotechnology and pharmaceutical firms, academia, and the U.S. Food and Drug Administration. Their contributions offer pharmaceutical and clinical researchers the most up-to-date understanding of the strategies used for and applications of biomarkers in drug development.